Valentina Volpin of RCI Regensburg identified novel genes in tumors which play role in resistance to T cell mediated killing in PD-L1 refractory human tumors using a high throughput RNAi screening. Learn more? Watch her award-winning #CIMT2021 eTalk. bit.ly/3jsYS8D

CIMT is proud to be supporting cancer immunotherapy researchers worldwide who are expanding treatment options for patients. #ResearchWorks #WorldCancerResearchDay #cancerimmunotherapy cimt.eu

SPOTLIGHT: Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer @tronmainz. Originally published in @Springer_Shop. To read our summary, click ow.ly/k1XR50HxZVm and scroll all the way down.

Uǧur Șahin is establishing a scientific department for #mRNA-based #cancer #immunotherapy at the Helmholtz Institute HI-TRON Mainz. In HI-TRON Mainz, DKFZ, @tronmainz, Universitätsmedizin Mainz and Universität Mainz cooperate. ➡️ bit.ly/3KIAb25

Excited Robbie Majzner Stanford Medicine will come to Mainz and share his research at #CIMT2022. Looking forward to his talk on #immunotherapy platforms for solid tumors. meeting.cimt.eu

Hear from Daniela Thommen The Netherlands Cancer Institute on dissecting and modulating reactive anti-tumor immunity in patient-derived tumor fragments #CIMT2022 on-site and online #cancerimmunotherapy meeting.cimt.eu

📢Excited to kick off activities for #Yscript project today – aiming at establishing a specific #mRNA #bioproduction process in yeast in order to develop novel therapeutics for many diseases. 🇫🇷Coordinated by Pichon Chantal, CNRS 🌍. 🇪🇺Funded by European Innovation Council. 👉yscript.eu.

New phase I/II trial data of CLDN6 CAR-T and CARVac-based in vivo expansion to treat patients with CLDN6+ advanced solid tumors. Andreas Mackensen Uniklinikum Erlangen will present. Meet him and other speakers at #CIMT2022 #cancerimmunotherapy meeting.cimt.eu

Joining CIMT from Johns Hopkins Medicine Kellie Smith Kellie N. Smith will talk about mechanisms of response and resistance to checkpoint blockade using integrated #immunogenomics. meeting.cimt.eu

Chiara Bonini Ospedale San Raffaele shares her expertise on #genome editing for cancer #immmunotherapy. We're excited to hear her talk at #CIMT2022 in Mainz, Germany. meeting.cimt.eu

Sharing results from preclinical studies on the targeting of myeloid derived suppressor cells in #cancer, Dmitry Gabrilovich will speak at #CIMT2022. Gabrilovich Lab #cancerimmunotherapy

📸 Our constructively discussing group of #researchers needs a coffee break ☕️ to strengthen for further fruitful exchange at the #Yscript kick-off meeting at the beautiful Centre International Hotel Dupanloup of Université d'Orléans. #mRNA #biotech European Innovation Council

Great science and conversations at the CIMT Poster Exhibit #CIMT2022 . 193 abstracts are being presented on-site at the Rheingoldhalle congress center.

Before we are exploring the vineyards around Illasi, Markus Maeurer presents #immunosurgery at ChampalimaudF which fuses research development and new treatments for patients with cancer Cancer Immunotherapy Summer School

Submit your abstract and get ready for #CICON23 in Milan. cancerimmunotherapyconference.org AACR Cancer Research Institute ENCI

CIMT crew Mustafa Diken, Christine Castle and Jan Beck having a great time @ #CICON23. Excellent science & great pizza. #cancerimmunotherapy in #milan

Early-career cancer immunologists: Learn and connect with peers and scientific leaders in an extraordinary retreat setting in the Austrian Alps, January 25-28, 2024. Apply by October 23, 2023. cimt.eu/winter-school

BioNTech has always been deeply rooted in academia. #STEM grads can now explore #science projects and apply for a full-time contract via our ATLAS #PhD program, a collab with TRON. Students with a sweet spot for #biomedical #research can apply by Oct 31. atlas-phdprogram.com/how-to-apply

New insights into overcoming immune deserts in tumors  @tronmainz  BioNTech SE. Read our digest here 👉 bit.ly/43t3LDl

At the 21st CIMT Annual Meeting Rafet Rafet Basar MD Anderson Cancer Center will present methods to enhance the potency of NK cellular therapy products using state of the art genetic engineering strategies. To register for #CIMT2024, go to meeting.cimt.eu